Springfield, NJ -- (SBWIRE) -- 12/20/2013 -- There are many instances in which a bone grafting procedure is required. Bone grafting is commonly performed in dental area, sometimes to maintain the support for existing tooth and sometimes in order to build a bony area to place dental implants. Dental implants require the presence of robust bone structure in maxilla or mandible to ensure successful placement and effective performance in the long-term. Orthogen, LLC has developed and commercialized a novel nanotechnology-based bone graft, NanoGen, for such applications. Orthogen, LLC is pleased to announce a new patent has been issued for NanoGen technology. NanoGen is already recognized as the first nanotechnology-based bone graft approved by the FDA for clinical use.
NanoGen is a nanocrystalline calcium sulfate material provided in the granular form. Once implanted in the body, it undergoes complete degradation and stimulates body to form its own bone. Recently published research in reputed journal Clincial Advances in Periodontology, which is an official journal of American Academy of Periodontology has demonstrated that up to 60% bone formed in the extraction sockets that were grafted with NanoGen. 100% of the bone was vital bone.
The NanoGen, offered by Orthogen, LLC can be used to treat a variety of conditions. Whether a periodontal treatment like infrabony defects, endodontic like apicoectomy or oral surgical procedures like socket grafting and sinus lifts, NanoGen can be effectively used to regenerate bone. For Most bone grafting procedures, NanoGen provides dentists and patients alike with a sense of confidence as the product handles and works well. Bone growth can be observed by the dental professionals on radiographs or computerized tomographic scans.
The clinical use of NanoGen has resulted in a plethora of positive reviews, experiences and testimonials from renowned dentists throughout the world, some of which can be viewed on their website. The success rate of this bone graft product is unmatched across the dental industry. To implement this highly effective product at a dental office, interested parties can order it online at shop.orthogencorp.com. For more information about the products Orthogen, LLC offers, please call 1-877-336-8643.
About Orthogen LLC
Originally a division of BioLok International, Orthogen LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications. Dr. Sachin Mamidwar serves as CEO of the company whereas Dr. Harold Alexander, previously Director of Orthopedic research at Hospital for Joint Diseases, New York serves as a Chairman of the Board. Orthogen offers various products including DentoGen®, NanoGen, related instruments and sutures used for dental applications. To inquire about the company’s products and technologies, please call 1-877-336-8643.
For more information, please visit http://www.orthogencorp.com/.